ArticleGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association2025

Lenvatinib suppress FGF19-FGFR4 signaling to enhance antitumor immune response in gastric cancer.

Yuya Maruyama et al.PubMed ↗Publisher ↗

No numbers read from the abstract.